Atea Pharmaceuticals, Inc.

UBS Group AG AVIR
Report date
3/31/2026
Quarter
2026 Q1
Filed
5/5/2026
Shares
109,950
Value ($000)
592
Weight
0.0%
2020 Q4 - 2026 Q1 (22 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).